Answer
Oct 01, 2025 - 05:54 AM
NUCALA (mepolizumab) is a monoclonal antibody used to treat severe eosinophilic asthma and other conditions. Long-term side effects may include increased risk of infections, hypersensitivity reactions, and potential immune system effects. As with any medication, patients should be monitored regularly by their healthcare provider for any adverse effects over time.
